4.7 Review

Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Treat and extend regimen for diabetic macular oedema-a systematic review and meta-analysis

Sheng Yang Lim et al.

Summary: This meta-analysis evaluated the outcomes of treat and extend (T&E) regimen in the treatment of CI-DMO. The results showed that T&E did not reduce the number of injections compared to landmark clinical trials, and the visual and anatomical outcomes in the first year were limited. However, T&E approach could reduce patient visits and treatment burden.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2023)

Review Ophthalmology

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma

Faruque Ghanchi et al.

Summary: In real-world settings, suboptimal compliance with frequent treatments and assessments can lead to undertreatment of eye diseases and pose a risk to vision. Longer-acting therapies that reduce the burden of treatment interventions are needed. Several longer-acting interventions for various eye diseases have been developed or are in late-phase development. This review provides an overview of these interventions and discusses the potential use of artificial intelligence to tailor treatment efficacy and reduce treatment burden.
Article Ophthalmology

The association of stroke with central and branch retinal arterial occlusion

Drew Scoles et al.

Summary: The risk of stroke is significantly increased in the days following a central or branch retinal artery occlusion (CRAO or BRAO), highlighting the importance of immediate referral to a stroke center upon diagnosis.
Article Pharmacology & Pharmacy

The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery

Shrirang Ranade et al.

Summary: The Port Delivery System is an innovative intraocular drug delivery system that continuously releases ranibizumab for the treatment of eye diseases. It has stable and soluble properties, and controlled release is achieved through a release control element. In vitro studies confirmed its reproducibility and demonstrated that it can maintain a stable release rate for at least 6 months.

DRUG DELIVERY (2022)

Article Ophthalmology

Stroke Risk before and after Central Retinal Artery Occlusion A Population-based Analysis

Kevin D. Chodnicki et al.

Summary: This population-based study demonstrated that the risk of symptomatic ischemic stroke is 2.2% in the 15 days before and after a CRAO, which is slightly lower than most studies from tertiary centers.

OPHTHALMOLOGY (2022)

Article Ophthalmology

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Nancy M. Holekamp et al.

Summary: This study evaluated the safety and efficacy of Port Delivery System (PDS) with ranibizumab for the treatment of neovascular age-related macular degeneration (nAMD). The results showed that PDS was noninferior and equivalent to monthly ranibizumab, with a high percentage of PDS-treated patients not requiring supplemental treatment within the first 24 weeks.

OPHTHALMOLOGY (2022)

Review Ophthalmology

CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS A Case Series and Review of the Literature

Alex Fonollosa et al.

Summary: This study describes the clinical and ophthalmologic features and outcomes of patients with coronavirus disease-19 and retinal vascular occlusions. The results show that retinal vein occlusion is the most frequent occlusive event in these patients, and most cases have favorable outcomes.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2022)

Article Ophthalmology

Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis

Bobeck S. Modjtahedi et al.

Summary: This study aims to assess whether there is a change in the incidence of retinal vascular occlusions after COVID-19 infection. The results showed that the incidence of new RVOs increased in the 6 months after COVID-19 infection, while the increase in RAOs was smaller. These events remain rare, and further research is needed to better understand their association with COVID-19 infection.

JAMA OPHTHALMOLOGY (2022)

Article Medicine, General & Internal

Contribution of Orbital Ultrasound to the Diagnosis of Central Retinal Artery Occlusion

Laura Rojas-Bartolome et al.

Summary: Orbital ultrasound has a high diagnostic value in the etiologic diagnosis of central retinal artery occlusion. The spot sign can be used as a guide for detecting embolic sources, while its absence may indicate the possibility of arteritis. Furthermore, calcium embolism plays a key role in the etiology.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Ophthalmology

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review

Kamal Kishore et al.

Summary: This review article provides a comprehensive overview of the current applications of intravitreal DEX implant in ophthalmic conditions. The article presents evidence of efficacy in various clinical situations, including retinal vein occlusion, diabetic macular edema, and uveitis, among others. Safety concerns such as cataract formation and progression, intraocular pressure elevation, and complications related to intravitreal injection are discussed.

CLINICAL OPHTHALMOLOGY (2022)

Article

Late retinal and optic nerve vascular complications due to COVID-19 in young individuals

Jaime Larrea et al.

American Journal of Ophthalmology Case Reports (2022)

Article Neurosciences

Similarities and differences in systemic risk factors for retinal artery occlusion and stroke: A nationwide case-control study

Marie Orskov et al.

Summary: This study compares risk factor profiles for thromboembolism among patients with retinal artery occlusion (RAO) and stroke, respectively. The study found a stronger association between RAO and atrial fibrillation, arterial hypertension, peripheral artery disease, retinal vein occlusion, cataract, and glaucoma, while the associations with diabetes, heart failure, ischemic heart disease, and renal disease were weaker.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2022)

Article Ophthalmology

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial

Margaret A. Chang et al.

Summary: This study evaluated treatment satisfaction and patient preference for the port delivery system (PDS) compared to intravitreal injections in patients with neovascular age-related macular degeneration (nAMD). The results showed that most patients assigned to PDS preferred this treatment method and both delivery methods had high treatment satisfaction.

JAMA OPHTHALMOLOGY (2022)

Article Medicine, General & Internal

Retinal Artery Occlusion and Its Impact on the Incidence of Stroke, Myocardial Infarction, and All-Cause Mortality during 12-Year Follow-Up

Joanna Roskal-Walek et al.

Summary: The aim of this study was to evaluate the incidence of ischemic stroke, myocardial infarction, and all-cause mortality in patients with retinal artery occlusion (RAO). The study found that patients with RAO had a higher risk of all-cause mortality compared to those without RAO. Additionally, patients with RAO who were younger than 75 years were significantly more likely to experience ischemic stroke, death, or the composite endpoint after an occlusion event, as compared with individuals without RAO.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Retinal Artery Occlusion and Associated Risk of Cerebrovascular Disease Related Hospitalization: A National Inpatient Study

Manpreet Kaur et al.

Summary: The study aimed to evaluate demographic and comorbid risk factors for cerebrovascular disease (CVD) hospitalization in patients with retinal artery occlusion (RAO) using a logistic regression model on data from the Nationwide Inpatient Sample (NIS) in 2019. It found that while demographics did not significantly impact the association with CVD hospitalization between RAO and non-RAO patients, comorbid diabetes and hypertension were prevalent in RAO patients, increasing the risk of CVD hospitalization. Patients with RAO also had a major severity of illness and adverse disposition, calling for a collaborative care model to improve their quality of life.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Ophthalmology

Emergency Department Presentation of Retinal Artery Occlusion

Salman J. Yousuf et al.

Summary: The study aimed to determine the frequency of brain imaging, carotid imaging, and cardiac testing, as well as hospitalization, among patients presenting to an emergency department with retinal artery occlusion (RAO). The results showed that a majority of patients did not receive emergency brain imaging, carotid imaging, or basic cardiac testing. A multidisciplinary approach is needed to raise awareness of the importance of treating RAO as a precursor to stroke or a stroke equivalent.

OPHTHALMOLOGY RETINA (2022)

Review Ophthalmology

Prevalence of Cilioretinal Arteries: A systematic review and a prospective cross-sectional observational study

Miklos Schneider et al.

Summary: The prevalence of CLRA varies depending on the method of identification, with unilateral presence and temporal location being more common. Our findings on the distribution pattern of CLRA in the Hungarian Caucasian population are similar to international literature, indicating that slightly more than one-third of the population has CLRA.

ACTA OPHTHALMOLOGICA (2021)

Article Ophthalmology

Risk of Retinal Artery Occlusion in Patients with Migraine

Ahmad Al-Moujahed et al.

Summary: The study found that migraine is associated with an increased risk of retinal artery occlusion (RAO), and migraine with aura is more likely to be associated with RAO compared to migraine without aura.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

Letter Ophthalmology

Risk factors for central retinal artery occlusion in young patients

Aditya Uppuluri et al.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2021)

Article Emergency Medicine

TRANSIENT MONOCULAR VISUAL LOSS: WHEN IS IT AN EMERGENCY?

Trishal Jeeva-Patel et al.

Summary: This article discusses the acute evaluation and potential causes of transient monocular vision loss, emphasizing the importance of focused attention and urgent management for patients with retinal ischemia and giant cell arteritis.

JOURNAL OF EMERGENCY MEDICINE (2021)

Article Medicine, General & Internal

Efficacy of YAG Laser Embolysis in Retinal Artery Occlusion

Mohammad Asim Mehboob et al.

Summary: The study compared the anatomical and functional success rates of conventional medical treatment and Nd:YAG laser embolysis in retinal artery occlusion, showing that Nd:YAG laser embolysis is more effective in treating fovea threatening retinal artery occlusion.

PAKISTAN JOURNAL OF MEDICAL SCIENCES (2021)

Article Ophthalmology

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study

Jean-Francois Korobelnik et al.

Summary: The study evaluated the efficacy and safety of IVT-AFL treat-and-extend dosing in patients with macular edema secondary to CRVO. Significant improvements in functional and anatomic outcomes were achieved, with most patients extending treatment intervals successfully. The safety profile of IVT-AFL was consistent with previous studies.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Ophthalmology

Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial

Takao Hirano et al.

Summary: The study findings suggest that a treat-and-extend (T&E) regimen using aflibercept with the longest treatment interval set to 16 weeks is a feasible and rational strategy for the treatment of diabetic macular edema (DME) over a period of 1 year. Although the improvement in best-corrected visual acuity (BCVA) may be slightly less compared to frequent treatment, the T&E aflibercept regimen shows promising results in terms of central subfield macular thickness (CST) improvement. Participants who demonstrated an early response to initial treatment showed greater vision improvement at 1 year, indicating the potential effectiveness of this treatment approach.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2021)

Review Clinical Neurology

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association

Brian Mac Grory et al.

Summary: Central retinal artery occlusion (CRAO) is an acute ischemic stroke that lacks scientific information and consistent management strategies, requiring more high-quality clinical trials. Acute CRAO is a medical emergency that necessitates early recognition and triage to emergency care.

STROKE (2021)

Article Multidisciplinary Sciences

Elevated retinal artery vascular resistance determined by novel visualized technique of laser speckle flowgraphy in branch retinal vein occlusion

Ryo Tomita et al.

Summary: This study aimed to investigate the increase in resistivity of the retinal artery in the branch retinal vein occlusion (BRVO)-affected area and to visualize it using laser speckle flowgraphy (LSFG). The results showed that the resistivity of retinal arteries in the affected area was significantly higher than in the unaffected area, and this increase was associated with the extent of retinal hemorrhage. These findings and techniques could help to further understand the pathophysiology of BRVO.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Blackout: Understanding transient vision loss

Rachael C Heath Jeffery et al.

Australian Journal of General Practice (2021)

Article Ophthalmology

Prospective trial of treat-and-extend regimen with aflibercept for branch retinal vein occlusion: 1-year results of the PLATON trial

Dong-Geun Park et al.

Summary: The treat-and-extend (TAE) regimen with aflibercept for treatment-naive macular edema (ME) secondary to branch retinal vein occlusion (BRVO) showed comparable efficacy to the fixed-dosing regimen over 52 weeks, with reduced treatment burden.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)

Review Medicine, General & Internal

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update

Andrzej Grzybowski et al.

Summary: Macular edema is commonly caused by retinal vein occlusion and diabetes, with anti-VEGF intravitreal injections replacing laser photocoagulation as the primary treatment. However, this treatment may require frequent injections and some patients may not respond well, indicating the need for alternative therapies and potential future use of artificial intelligence in treatment selection.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Neurosciences

Associations Between Retinal Artery/Vein Occlusions and Risk of Vascular Dementia

Cecilia S. Lee et al.

Summary: The study found that older patients who present with RAVO and carry the APOE epsilon 4 allele appear to be at higher risk for vascular dementia. There were no significant associations between RAVO and AD in either APOE group.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Peripheral Vascular Disease

Usefulness of orbital colour Doppler ultrasound in vascular-related monocular vision loss

Gerardo Ruiz-Ares et al.

Summary: This study investigated the vascular aetiology of acute, painless, monocular vision loss (APMVL) using colour Doppler imaging. The results showed that central retinal artery occlusion and ischemic optic neuropathy were common causes of persistent vision loss among patients with APMVL.

VASCULAR MEDICINE (2021)

Review Cell Biology

Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

Josh O. Wallsh et al.

Summary: This article reviews the central role of anti-vascular endothelial growth factor (anti-VEGF) therapy in treating various retinal diseases, as well as the subset of patients who do not respond effectively. It also discusses alternative treatment options for these cases and future research directions for anti-VEGF-resistant eyes.

CELLS (2021)

Article Ophthalmology

Relationship between Retinal Vascular Occlusions and Cognitive Dementia in a Large Cross-Sectional Cohort

Alison X. Chan et al.

Summary: Individuals with retinal vascular occlusions have a higher prevalence of dementia, but this association is mainly due to shared underlying risk factors such as older age and stroke, rather than a direct impact.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Neurosciences

Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution

Wesley Chan et al.

Summary: Patients with acute central retinal artery occlusion (CRAO) often present late, leading to delayed diagnosis. Those presenting within 24 hours are more likely to be admitted and receive comprehensive stroke work-up. Only a small number of patients received intravenous thrombolysis.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Ophthalmology

Risk of Stroke, Myocardial Infarction, and Death Among Patients With Retinal Artery Occlusion and the Effect of Antithrombotic Treatment

Nanna Vestergaard et al.

Summary: This study evaluated the risk of stroke, MI, and death in patients with retinal artery occlusion (RAO) and the impact of various antithrombotic treatments for secondary prevention. Patients with RAO had increased risks for all three outcomes, which persisted for more than 1 year. There was no protective effect of antithrombotic treatments within the first year after RAO.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)

Article Medicine, General & Internal

Central and Branch Retinal Artery Occlusion-Do They Harbor the Same Risk of Further Ischemic Events?

Joanna Roskal-Walek et al.

Summary: The study found that patients with central retinal artery occlusion (CRAO) and branch retinal artery occlusion (BRAO) have similar prognosis in terms of ischemic stroke, myocardial infarction, and all-cause mortality. The frequency of ischemic strokes occurring before and after RAO is similar, while myocardial infarctions are significantly more common before an episode of RAO.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion: 2-Year Prospective Study Outcomes

Yusuke Arai et al.

Summary: This study evaluated the long-term efficacy and safety of a modified treat-and-extend regimen of aflibercept for macular edema due to branch retinal vein occlusion. Results showed significant improvements in visual acuity and central subfield thickness over 24 months, with potential for reducing injection and clinic visit frequency.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Ophthalmology

Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion

Pali P. Singh et al.

Summary: The study found that the use of systemic antiplatelet or anticoagulant agents was associated with an increased prevalence of CME and foveal hemorrhage at the initial presentation of BRVO, but was not associated with different visual or structural outcomes at the final follow-up.

THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)

Review Ophthalmology

KSI-301: antibody biopolymer conjugate in retinal disorders

Priya R. Chandrasekaran et al.

Summary: KSI-301, a novel intravitreal anti-VEGF antibody biopolymer conjugate, has shown promising results in retinal vascular diseases with extended duration, durability, safety, and efficacy, potentially addressing treatment burden and improving outcomes.

THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)

Article Medicine, General & Internal

Prevalence of subclinical retinal ischemia in patients with cardiovascular disease - a hypothesis driven study

Christopher P. Long et al.

Summary: The study investigated the potential of retinal ischemic perivascular lesions (RIPLs) as a biomarker for cardiovascular disease by analyzing RIPLs in patients with documented cardiovascular disease and healthy controls. The presence of RIPLs, which are anatomical markers of prior retinal ischemic infarcts, was associated with higher odds of cardiovascular disease and may serve as an additional biomarker for identifying patients at risk of adverse cardiovascular events.

ECLINICALMEDICINE (2021)

Editorial Material Ophthalmology

Faricimab: expanding horizon beyond VEGF

Ashish Sharma et al.

Article Clinical Neurology

Retinal Vascular Signs and Cerebrovascular Diseases

Tyler Hyungtaek Rim et al.

JOURNAL OF NEURO-OPHTHALMOLOGY (2020)

Article Neurosciences

Prevalence of Retinal Emboli and Acute Retinal Artery Occlusion in Acute Ischemic Stroke

Robert A. Egan et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Review Clinical Neurology

Thrombolytic Therapy for Acute Central Retinal Artery Occlusion

Brian Mac Grory et al.

STROKE (2020)

Article Ophthalmology

Correlation of the history of stroke and the retina artery occlusion: a nested case-control study

Yue-Yan Xiao et al.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2020)

Editorial Material Biotechnology & Applied Microbiology

Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces

Miguel A. Gonzalez-Gay et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2020)

Review Ophthalmology

Iatrogenic ophthalmic artery occlusion and retinal artery occlusion

Jong Suk Lee et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Lipid Signaling in Ocular Neovascularization

Ryo Terao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation post central retinal artery occlusion: Role of implantable loop recorders

Ryan A. Watson et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)

Article Neurosciences

Assessing the risk of stroke development following retinal artery occlusion

Ibraheem S. Shaikh et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Review Hematology

Inherited and acquired thrombophilia in adults with retinal vascular occlusion: A systematic review and meta-analysis

Giulio Francesco Romiti et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Medicine, General & Internal

Retinal vascular occlusions

Ingrid U Scott et al.

LANCET (2020)

Review Medicine, General & Internal

Cytokines and Pathogenesis of Central Retinal Vein Occlusion

Hidetaka Noma et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Ophthalmology

Human coronaviruses: ophthalmic manifestations

Mohd-Asyraaf Abdul-Kadir et al.

BMJ OPEN OPHTHALMOLOGY (2020)

Article Medicine, General & Internal

Retinal findings in patients with COVID-19: Results from the SERPICO-19 study

Alessandro Invernizzi et al.

ECLINICALMEDICINE (2020)

Article Ophthalmology

INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION A Randomized Clinical Trial

Manuel Casselholm de Salles et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)

Article Medicine, General & Internal

Stroke Risk Before and After Central Retinal Artery Occlusion in a US Cohort

Kevin D. Chodnicki et al.

MAYO CLINIC PROCEEDINGS (2019)

Review Ophthalmology

Association of glaucoma with risk of retinal vein occlusion: A meta-analysis

Xue Yin et al.

ACTA OPHTHALMOLOGICA (2019)

Review Ophthalmology

Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion

Hidetaka Noma et al.

JOURNAL OF OPHTHALMOLOGY (2019)

Review Public, Environmental & Occupational Health

Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors

Peige Song et al.

JOURNAL OF GLOBAL HEALTH (2019)

Review Ophthalmology

Arteriovenous crossing associated with branch retinal vein occlusion

Yuki Muraoka et al.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2019)

Article Multidisciplinary Sciences

Thrombophilic risk factors for retinal vein occlusion

Maria J. Vieira et al.

SCIENTIFIC REPORTS (2019)

Review Ophthalmology

Intra-Arterial Thrombolysis for Central Retinal Artery Occlusion

Navid Hakim et al.

CLINICAL OPHTHALMOLOGY (2019)

Article Ophthalmology

Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study

Rahul N. Khurana et al.

INTERNATIONAL JOURNAL OF RETINA AND VITREOUS (2019)

Article Clinical Neurology

Risk of Acute Ischemic Stroke in Patients With Monocular Vision Loss of Vascular Etiology

Lucy Y. Zhang et al.

JOURNAL OF NEURO-OPHTHALMOLOGY (2018)

Article Pharmacology & Pharmacy

Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model

Yoshifumi Hida et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)

Article Ophthalmology

Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion

Patrick Lavin et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)

Article Ophthalmology

Management of Transient Monocular Vision Loss and Retinal Artery Occlusions

Ivana Vodopivec et al.

SEMINARS IN OPHTHALMOLOGY (2017)

Article Ophthalmology

Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®

Timothy W. Olsen et al.

OPHTHALMOLOGY (2017)

Article Ophthalmology

RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION

Yuko Miwa et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)

Article Ophthalmology

Update on the evaluation of transient vision loss

John H. Pula et al.

CLINICAL OPHTHALMOLOGY (2016)

Article Ophthalmology

Ocular vascular occlusive disorders: Natural history of visual outcome

Sohan Singh Hayreh

PROGRESS IN RETINAL AND EYE RESEARCH (2014)

Article Ophthalmology

Treat-and-Extend Intravitreal Bevacizumab for Branch Retinal Vein Occlusion

Ryan B. Rush et al.

OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2014)

Review Clinical Neurology

Treatment Options for Central Retinal Artery Occlusion

Sudha Cugati et al.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2013)

Letter Ophthalmology

H1N1-associated Acute Retinitis

Lana Rifkin et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2012)

Article Ophthalmology

The Incidence of Central Retinal Artery Occlusion in Olmsted County, Minnesota

Jacqueline A. Leavitt et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)

Article Ophthalmology

Natural History of Visual Outcome in Central Retinal Vein Occlusion

Sohan Singh Hayreh et al.

OPHTHALMOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Cardiovascular risk factors and outcome in patients with retinal vein occlusion

Mirko Di Capua et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)

Article Medicine, General & Internal

Retinal-Vein Occlusion.

Tien Y. Wong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Ophthalmology

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

David M. Brown et al.

OPHTHALMOLOGY (2010)

Article Ophthalmology

Branch retinal artery occlusion: Visual prognosis

John O. Mason et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)

Article Ophthalmology

Prevalence and risk factors of retinal vein occlusion in an Asian population

L. L. Lim et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2008)

Article Biotechnology & Applied Microbiology

Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator

Peter A. Campochiaro et al.

MOLECULAR THERAPY (2008)

Review Ophthalmology

Prevalent misconceptions about acute retinal vascular occlusive disorders

SS Hayreh

PROGRESS IN RETINAL AND EYE RESEARCH (2005)

Article Clinical Neurology

Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion

M Arnold et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Ophthalmology

Visual outcome in central retinal and branch retinal artery occlusion

D Yuzurihara et al.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2004)

Article Ophthalmology

Hematologic abnormalities associated with various types of retinal vein occlusion

SS Hayreh et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2002)